PA-23-189: Research Supplements to Promote Diversity in Health-Related Research (Admin Supp Clinical Trial Not Allowed)
Closed
This grant is closed. Who won this program's grants before is below, and similar open grants are at the end of the page. It is in our archive of National Institutes of Health notices from 2023.
National Institutes of Health offered grants of up to $500,000 to small businesses. Applications closed on February 21, 2025.
From the official notice on Grants.gov, last changed February 21, 2025. Checked November 7, 2026.
- Award ceiling$500,000
- Cost sharingNot required
- Funding typeGrant
About this NIH notice
- Activity codeR01 / R35 / R00 / R21 / U01 / RF1 / R37 / R15 / P50 / U54 / DP2 / P01 / R16 / R03 / R33 / U24 / DP5 / UM1 / UL1 / DP1 / R44 / UH3 / R61 / U19 / RM1 / P30 / R34 / UC2 / UG1 / P2C / P20 / R24 / P40 / UG3 / U2C / RC2 / R18 / P51
- Clinical trialsNot allowed
- Funded byNCI, NIGMS, NINDS
- Median yearly award$67,330
- Typical project length4 years
- R01, Research Project Grant. NIH's standard grant for a defined research project led by a named investigator, usually for up to five years. Other open R01 notices.
- R35, Outstanding Investigator Award. Support for an investigator's whole research program rather than a single project (this includes MIRA awards). Other open R35 notices.
- R00, Research Transition Award. The independent phase of the K99/R00 Pathway to Independence award. Other open R00 notices.
- R21, Exploratory/Developmental Research Grant. Early, exploratory ideas that may not have preliminary data yet, usually for up to two years. Other open R21 notices.
- U01, Research Project Cooperative Agreement. Like an R01, but NIH staff are substantially involved in the work. Other open U01 notices.
- R15, Research Enhancement Award. Small research projects at institutions that receive little NIH funding, with students taking part in the research. Other open R15 notices.
- P50, Specialized Center Grant. A research center on one disease or topic, with several projects and shared cores. Other open P50 notices.
- U54, Specialized Center Cooperative Agreement. A research center with several projects and shared cores, with substantial NIH involvement. Other open U54 notices.
- DP2, NIH Director's New Innovator Award. Support for an early-stage investigator's highly innovative project. Other open DP2 notices.
- P01, Research Program Project Grant. Several related research projects around one theme, with shared core facilities. Other open P01 notices.
- R16, Support for Research Excellence. Research at institutions with limited NIH funding, to build their research capacity. Other open R16 notices.
- R03, Small Grant. A small, short project such as pilot work, a feasibility study, secondary data analysis or a new method, usually for up to two years. Other open R03 notices.
- R33, Exploratory/Developmental Grant Phase II. The second phase of a phased award, usually following an R61 or R21 phase. Other open R33 notices.
- U24, Resource-Related Research Project Cooperative Agreement. Shared research resources such as data centers or coordinating centers, with substantial NIH involvement. Other open U24 notices.
- UM1, Research Project with Complex Structure Cooperative Agreement. A large research project with several connected parts, with substantial NIH involvement. Other open UM1 notices.
- DP1, NIH Director's Pioneer Award. Support for an exceptionally creative scientist's high-risk, high-impact ideas. Other open DP1 notices.
- R44, Small Business Innovation Research (SBIR) Phase II. Full research and development of an SBIR project after Phase I (or both phases at once, called Fast Track). Other open R44 notices.
- UH3, Exploratory/Developmental Cooperative Agreement Phase II. The second phase of a phased cooperative agreement, usually following a UG3 or UH2 phase. Other open UH3 notices.
- R61, Exploratory/Developmental Phase I. The first phase of a phased award. Moving on to the R33 phase depends on meeting agreed milestones. Other open R61 notices.
- U19, Research Program Cooperative Agreement. Several related projects under one award, with substantial NIH involvement. Other open U19 notices.
- RM1, Research Project with Complex Structure. A large research project with several connected parts under one award. Other open RM1 notices.
- P30, Center Core Grant. Shared facilities and services for investigators who already hold research funding on a common theme. Other open P30 notices.
- R34, Planning Grant. Planning a clinical trial: design, protocol and feasibility work before the trial itself. Other open R34 notices.
- P20, Exploratory Grant. Planning or building a research center or program. Other open P20 notices.
- R24, Resource-Related Research Project. Resources that serve a research field, such as databases, tools or shared methods. Other open R24 notices.
- UG3, Exploratory/Developmental Phase I Cooperative Agreement. The first phase of a phased cooperative agreement. Moving on to the UH3 phase depends on meeting agreed milestones. Other open UG3 notices.
Projects funded under PA-23-189 were run by National Cancer Institute (NCI, 159 projects), National Institute of General Medical Sciences (NIGMS, 125 projects), National Institute of Neurological Disorders and Stroke (NINDS, 112 projects) and National Heart Lung and Blood Institute (NHLBI, 105 projects), and 20 more. Contact the program officer at the institute that fits your project before you apply; the notice lists them.
Application due dates, page limits and budget limits are set in the notice. Read PA-23-189 in the NIH Guide.
Key dates
| Posted | June 28, 2023 |
|---|---|
| Deadline | February 21, 2025 |
| Archived by Grants.gov | February 22, 2025 |
Who can apply
This opportunity was open to small businesses.
- Small businesses
Other Eligible Applicants include the following:Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the HHS Grants Policy Statement, are not allowed. See full Notice of Funding Opportunity for additional details on Eligibility.
Is this a realistic fit?
- Projects NIH funded under this notice had a median yearly award of $67,330; it allows up to $500,000 per award.
- Most of the program's money (35% over five years) went to nonprofits.
- No cost sharing or match is required.
What the grant funds
The National Institutes of Health (NIH) and the Centers for Disease Control and Prevention hereby notify Program Director(s)/Principal Investigator(s) (PD(s)/PI(s)) holding specific types of research grants (activity codes listed above) that funds are available for administrative supplements to enhance the diversity of the research workforce by recruiting and supporting students, postdoctorates, and eligible investigators from diverse backgrounds, including those from groups that have been shown to be underrepresented in health-related research. This supplement opportunity is also available to PD(s)/PI(s) of research grants who are or become disabled and need additional support to accommodate their disability in order to continue to work on the research project. Administrative supplements must support work within the scope of the original project. This Notice of Funding Opportunity (NOFO) is designed specifically for applicants proposing research that does not involve leading an independent clinical trial, a clinical trial feasibility study, or an ancillary clinical trial. Applicants to this NOFO are permitted to propose research experience in a clinical trial led by a mentor or co-mentor.
Funded under PA-23-189 so far
NIH funded 1,010 projects under PA-23-189 in fiscal 2023 to 2026, at 240 institutions. The median yearly award was $67,330.
| Project | Institution | Fiscal year | Award |
|---|---|---|---|
| Modeling Drug Induced Liver Injury with Patient-Derived Liver Organoids and Microfluidic Chips | University of Michigan at Ann Arbor | 2026 | $43,427 |
| Clinical markers of DLD in bilingual and monolingual Vietnamese children - Diversity Supplement L. Dang | San Diego State University | 2026 | $39,032 |
| Toolkit for Fast, Multipurpose and Inducible Bioorthogonal Chemistry | University of Delaware | 2026 | $69,747 |
| Supplement: Developmental programming of stress-sensitive neural circuits underlying social behavior | University of California at Davis | 2026 | $39,303 |
| Roles of Recycling Endosomes in Neuronal Extracellular Vesicle Cargo Traffic | Brandeis University | 2026 | $79,452 |
| Membrane trafficking to lysosomes | University of Colorado | 2026 | $14,365 |
| Roles of the ER Stress Surveillance Pathway During the Cell Cycle | University of California, San Diego | 2026 | $33,711 |
| Platform for in vivo Metabolism | University of Georgia | 2026 | $25,149 |
Who has won Food and Drug Administration Research grants before
From fiscal 2021 to 2025, Food and Drug Administration Research (93.103) awarded $1.2 billion across 940 grant awards, an average of $1.3 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| The Critical Path Institute | Arizona | 13 | $94.0 million |
| National Environmental Health Association | Colorado | 9 | $55.4 million |
| Association of Food & Drug Officials | Pennsylvania | 14 | $50.3 million |
| The Medical Device Innovation Consortium | Virginia | 1 | $48.6 million |
| Duke University | North Carolina | 11 | $35.6 million |
Applying now
This notice no longer takes applications. Agencies often post the same opportunity again under a new number, so check the program's notices on Grants.gov and the similar open grants below.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is PA-23-189 still open?
No. It closed on February 21, 2025.
Who can apply for Research Supplements to Promote Diversity in Health-Related Research (Admin Supp Clinical Trial Not Allowed)?
National Institutes of Health accepted applications from small businesses. The notice adds further conditions, so read its eligibility section.
What is the deadline for Research Supplements to Promote Diversity in Health-Related Research (Admin Supp Clinical Trial Not Allowed)?
Closed February 21, 2025. Applications are no longer accepted; the program's newer notices are on this page when there are any.
How much funding is available?
Awards of up to $500,000 each.
Who has been funded under PA-23-189?
NIH RePORTER lists 1,010 projects funded under PA-23-189 in fiscal 2023 to 2026, at 240 institutions. The most were at University of California, San Francisco, Stanford University, University of California at Davis.
Who has won Food and Drug Administration Research grants before?
The largest recipients over five fiscal years were The Critical Path Institute, National Environmental Health Association, Association of Food & Drug Officials. The program made 940 awards worth $1.2 billion in that time.
Similar open grants
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
- Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required)
- Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required)